Determining information for inclusion in a decision-support intervention for clinical trial participation : A modified Delphi approach

Peer reviewedPostprin

Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer

UCAN Cancer Charity (www.ucanhelp.org.uk) and MacMillan Cancer Charity (www.macmillan.org.uk) helped design and conduct the study.Peer reviewedPostprin

A core outcome set for localised prostate cancer effectiveness trials : protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey

Acknowledgements We would like to thank Professor Craig Ramsay, Professor Luke Vale, and Professor Vikki Entwistle for their comments on earlier drafts of the protocol. This study is funded by the Cancer Research Aberdeen and North East Scotland (CRANES) charity. Paula Williamson would like to acknowledge funding from the European Union Seventh Framework Programme (FP7/2007-2013, FP7/2007-2011) under grant agreement number 305081 for the COMET initiative, which provided support for this work.Peer reviewedPublisher PD

Increasing Engagement for Breast Cancer Screening and Treatment : The "ICANTREAT" Community of Expertise Initiative

Funding The workshop and the travel for four researchers – AP, SN, RS and SJM was enabled through the Scottish Funding Council (grant number SF10192) grant.Peer reviewedPublisher PD

Survivorship data in Prostate Cancer : Where are we and where do we need to be?

Funding/Support and role of the sponsor: PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The funding bodies played no direct role in this study. The views communicated here are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any associated partners are responsible for any use that may be made of the information contained herein.Peer reviewedPublisher PD

Eye Movement Patterns Can Distinguish Schizophrenia From the Major Affective Disorders and Healthy Control Subjects

Open Access under the OUP Agreement Funding This project was supported by the following grants: The Royal Society of London, Chief Scientist Office Scotland (CZB/4/734), NHS Grampian Tenovus Scotland (G12/31), NHS Grampian Endowment Fund, Miller MacKenzie Trust, EU-FP6 (SGENE) and Health Innovation Challenge Fund, jointly from Wellcome Trust and Department of Health (WT-103911/Z/14/Z). The funders had no role in the original study design, the ongoing data collection and analysis, interpretation, or writing of the manuscript. We thank all who helped with clinical aspects of the study including research assistants Barbara Duff, Kate Cotton, Foteini Okonomitsiou, Elizabeth Hannaford, Zsuszanna Nemeth and Joanna Rodzinko Paska as well as the patients and volunteers whose help was indispensable. P Benson and D St Clair are co-founders of SACCADE Diagnostics Ltd a spin out company tasked to develop eye movement technology to assist diagnosis of major mental health disorders. The University of Aberdeen has patents pending in Europe (PCT/GB2013/050016) and USA (14/370,611). The data reported in this paper arose solely from funding by the acknowledged UK research bodies and charities none of whom have vested interests in the company. David St Clair had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Design of study and development of protocols: D St Clair, P Benson and S Beedie. Recruitment of patients, case note review and clinical and eye movement data collection, quality control and feature extraction of eye movement variables: St Clair, Rujescu, MacIntosh, Beedie, Lemmon, Nouzova. Drafting of the manuscript: St Clair and Nath. Critical revision of manuscript for important intellectual content: all authors. Statistical analyses: Nath and Benson. Interpretation of results: Nath, Benson, MacLennan and St Clair. Obtained funding: St Clair, Benson, MacIntosh, Rujescu. Supervision: St Clair, Benson, MacIntosh, Nath, Rujescu.Peer reviewedPublisher PD

Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones : the TISU non-inferiority RCT

Acknowledgements The authors wish to thank the patients who participated in the TISU trial.We also thank Stanley Coutts (patient representative) and Charles Clark (patient representative and co-applicant) for their contribution to the design of the participant-facing documents (patient information sheet and questionnaires); Sharon Wren for her secretarial support and data management; previous data co-ordinators, Jessica Wood and Margery Heath, for their data and trial management support; the CHaRT programming team led by Gladys McPherson (to 2016) and Mark Forrest (2016–present); other staff within CHaRT and the HSRU for their assistance with the trial (Cynthia Fraser); members of the PMG for their ongoing advice and support of the trial, plus the independent members of the TSC and DMC; and the staff at the recruitment sites who facilitated the recruitment, treatment and follow-up of trial participants (all listed below); and, finally, we would like to thank the National Institute for Health Research and the Health Technology Assessment programme for funding the TISU trial. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 26, No. 19. See the NIHR Journals Library website for further project information.Peer reviewedPublisher PD

Unanswered questions in prostate cancer : Findings of an international multi-stakeholder consensus by the PIONEER Consortium

Acknowledgements PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint under- taking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.Peer reviewedPostprin

The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

Funding/Support and role of the sponsor: This research was supported by funding under the PIONERR Consortium. The Consortium played a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript.Peer reviewedPublisher PD

Diagnostic and prognostic factors in patients with prostate cancer : a systematic review

Funding PIONEER is funded through the IMI2 Joint Undertaking and is listed under Grant Agreement No. 777492 and is part of the Big Data for Better Outcomes Programme (BD4BO). IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views communicated within are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.Peer reviewedPublisher PD